TRImaran Pharma Inc is
a company focused on
the development and
commercialization of
unique pyran structured
Triple Reuptake Inhibitors
(TRIs) targeting Central
Nervous System (CNS)
disorders such as PTSD,
MDD and ADHD.

Copyright 2016 TRImaran Pharma, Inc. All rights reserved. 

New Treatments Are Still Needed

There is great unmet need in the pharmacotherapy of a
number of psychiatric disorders due to the low efficacy and side effects of currently used drugs... read more